Joel Charrow

12.1k total citations
143 papers, 7.1k citations indexed

About

Joel Charrow is a scholar working on Physiology, Epidemiology and Molecular Biology. According to data from OpenAlex, Joel Charrow has authored 143 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Physiology, 41 papers in Epidemiology and 28 papers in Molecular Biology. Recurrent topics in Joel Charrow's work include Lysosomal Storage Disorders Research (62 papers), Neurofibromatosis and Schwannoma Cases (27 papers) and Carbohydrate Chemistry and Synthesis (25 papers). Joel Charrow is often cited by papers focused on Lysosomal Storage Disorders Research (62 papers), Neurofibromatosis and Schwannoma Cases (27 papers) and Carbohydrate Chemistry and Synthesis (25 papers). Joel Charrow collaborates with scholars based in United States, United Kingdom and Australia. Joel Charrow's co-authors include Robert Listernick, Neal J. Weinreb, Mark J. Greenwald, Robert Listernick, Pramod K. Mistry, Barry E. Rosenbloom, Paige Kaplan, Rebecca S. Wappner, Gregory M. Pastores and Edwin H. Kolodny and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and SHILAP Revista de lepidopterología.

In The Last Decade

Joel Charrow

136 papers receiving 6.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel Charrow United States 46 4.1k 2.8k 1.8k 1.5k 1.4k 143 7.1k
Robert J. Hopkin United States 40 2.8k 0.7× 1.5k 0.5× 632 0.3× 1.5k 1.0× 716 0.5× 189 5.8k
Gregory M. Pastores United States 50 7.5k 1.8× 3.1k 1.1× 599 0.3× 2.2k 1.4× 2.8k 2.0× 204 8.8k
Bruno Bembi Italy 43 4.2k 1.0× 1.2k 0.4× 737 0.4× 1.4k 0.9× 1.5k 1.0× 133 5.4k
Dominique P. Germain France 49 7.7k 1.9× 3.6k 1.3× 661 0.4× 1.7k 1.1× 2.3k 1.6× 218 10.0k
Michael Beck Germany 59 10.9k 2.7× 5.2k 1.9× 606 0.3× 1.6k 1.1× 2.3k 1.6× 213 12.2k
Nathalie Guffon France 35 5.2k 1.3× 2.4k 0.8× 218 0.1× 1.2k 0.8× 914 0.6× 138 6.5k
Paige Kaplan United States 42 2.9k 0.7× 1.5k 0.5× 191 0.1× 1.6k 1.1× 1.2k 0.8× 135 5.7k
Christine M. Eng United States 34 2.7k 0.7× 1.3k 0.5× 229 0.1× 1.3k 0.9× 646 0.5× 81 5.7k
Mirella Filocamo Italy 34 2.5k 0.6× 903 0.3× 268 0.1× 1.9k 1.2× 1.1k 0.8× 158 4.3k
Anna Tylki‐Szymańska Poland 39 4.1k 1.0× 1.8k 0.7× 139 0.1× 1.6k 1.0× 1.4k 0.9× 263 5.4k

Countries citing papers authored by Joel Charrow

Since Specialization
Citations

This map shows the geographic impact of Joel Charrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Charrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Charrow more than expected).

Fields of papers citing papers by Joel Charrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Charrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Charrow. The network helps show where Joel Charrow may publish in the future.

Co-authorship network of co-authors of Joel Charrow

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Charrow. A scholar is included among the top collaborators of Joel Charrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Charrow. Joel Charrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Savarirayan, Ravi, William R. Wilcox, Paul Harmatz, et al.. (2024). P131: Persistence of growth-promoting effects in infants and toddlers with achondroplasia: Results from a phase II extension study with vosoritide*. SHILAP Revista de lepidopterología. 2. 101028–101028. 1 indexed citations
2.
Mistry, Pramod K., Manisha Balwani, Joel Charrow, et al.. (2024). Long‐term effectiveness of eliglustat treatment: A real‐world analysis from the International Collaborative Gaucher Group Gaucher Registry. American Journal of Hematology. 99(8). 1500–1510. 3 indexed citations
3.
Kim, Katherine, et al.. (2023). Treatment-naive and post-treatment glucosylsphingosine (lyso-GL1) levels in a cohort of pediatric patients with Gaucher disease. Molecular Genetics and Metabolism. 141(1). 107736–107736. 4 indexed citations
4.
5.
Piri‐Moghadam, Hamed, et al.. (2022). A rapid LC-MS/MS assay for detection and monitoring of underivatized branched-chain amino acids in maple syrup urine disease. SHILAP Revista de lepidopterología. 24. 107–117. 14 indexed citations
6.
Irving, Melita, Joel Charrow, Valérie Cormier‐Daire, et al.. (2018). Vosoritide for Children with Achondroplasia: A 30 Month Update from an Ongoing Phase 2 Clinical Trial. Hormone Research in Paediatrics. 89.
7.
Balwani, Manisha, Thomas Andrew Burrow, Joel Charrow, et al.. (2015). Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States. Molecular Genetics and Metabolism. 117(2). 95–103. 53 indexed citations
8.
Charrow, Joel, Hiroyuki Ida, Carla E. M. Hollak, et al.. (2014). EDGE: A Phase 3 study evaluating once versus twice daily dosing of eliglustat in patients with Gaucher disease type 1: interim results from the lead-in-period. Molecular Genetics and Metabolism. 111(2). S30–S30. 1 indexed citations
9.
Ploeg, Ans T. van der, Richard J. Barohn, Lisa Carlson, et al.. (2012). Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa. Molecular Genetics and Metabolism. 107(3). 456–461. 85 indexed citations
10.
Charrow, Joel. (2008). Enzyme replacement therapy for Gaucher disease. Expert Opinion on Biological Therapy. 9(1). 121–131. 28 indexed citations
11.
Epstein, Leon G., Ali Jalali, Joshua V. Ross, et al.. (2008). Neuroimaging findings in children with rare or novel de novo chromosomal anomalies. Birth Defects Research Part A Clinical and Molecular Teratology. 82(4). 200–210. 1 indexed citations
12.
Charrow, Joel, et al.. (2006). Orbital optic nerve gliomas in children with neurofibromatosis type 1. Journal of American Association for Pediatric Ophthalmology and Strabismus. 10(6). 534–539. 36 indexed citations
13.
Andersson, Hans C., Joel Charrow, Paige Kaplan, et al.. (2005). Individualization of long-term enzyme replacement therapy for Gaucher disease. Genetics in Medicine. 7(2). 105–110. 89 indexed citations
14.
Sarwark, John F., et al.. (2000). Neural tube defects and the 13q deletion syndrome: Evidence for a critical region in 13q33-34. American Journal of Medical Genetics. 91(3). 227–230. 53 indexed citations
15.
Charrow, Joel, Joan A. Esplin, Paige Kaplan, et al.. (1999). Recommendations for Diagnosis, Evaluation, and Monitoring of Patients With Gaucher Disease. JAMA Internal Medicine. 159(11). 1255–1255. 1 indexed citations
16.
Mazur, Alice, Orly Manor, Joel Charrow, et al.. (1996). Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase. The Journal of Pediatrics. 129(1). 149–153. 84 indexed citations
17.
Listernick, Robert, Joel Charrow, Mark J. Greenwald, & Nancy B. Esterly. (1989). Optic gliomas in children with neurofibromatosis type 1. The Journal of Pediatrics. 114(5). 788–792. 221 indexed citations
18.
Höefler, Gerald, Sigrid Hoefler, Paul A. Watkins, et al.. (1988). Biochemical abnormalities in rhizomelic chondrodysplasia punctata. The Journal of Pediatrics. 112(5). 726–733. 112 indexed citations
19.
Hebert, Adelaide A., Joel Charrow, Nancy B. Esterly, et al.. (1987). Uncombable hair (pili trianguli et Canaliculi): Evidence for dominant inheritance with complete penetrance based on scanning electron microscopy. American Journal of Medical Genetics. 28(1). 185–193. 18 indexed citations
20.
Paller, Amy S., et al.. (1983). Pedal hemangiomas in Turner syndrome. The Journal of Pediatrics. 103(1). 87–88. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert J. Hopkin Breakdown of academic impact, for papers by Gregory M. Pastores Breakdown of academic impact, for papers by Bruno Bembi Breakdown of academic impact, for papers by Dominique P. Germain Breakdown of academic impact, for papers by Michael Beck Breakdown of academic impact, for papers by Nathalie Guffon Breakdown of academic impact, for papers by Paige Kaplan Breakdown of academic impact, for papers by Christine M. Eng Breakdown of academic impact, for papers by Mirella Filocamo Breakdown of academic impact, for papers by Anna Tylki‐Szymańska
Rankless by CCL
2026